Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
GLP-1 Receptor Agonists vs. DPP-4 inhibitors.
| Parameter | GLP-1 receptor agonists | DPP-4 inhibitors |
|---|---|---|
| Total cholesterol | Stimulate effective reduction | Minor reduction only |
| Weight control | Weight loss | Weight neutral |
| Safety profile | Gastrointestinal side-effects such as nausea. | Well tolerated |
| Mode of administration | As injectable peptides (Except for oral form of semaglutide) | Small agents can be taken orally |
